4 Biotechs Facing Do-or-Die Catalysts in December Post author:Sam Post published:December 5, 2017 Post category:BioPharma As 2018 winds down, it’s not over for some biopharma companies. Source: BioSpace You Might Also Like GlaxoSmithKline Poaches Another Top Exec—This Time From Pfizer July 12, 2017 SoCal's Artelo Biosciences Inks $202M+ R&D Deal With the NEOMED Institute January 29, 2018 Troubling Times for Shire as Execs Jump Ship and Employee Satisfaction is at an All Time Low August 30, 2017
Troubling Times for Shire as Execs Jump Ship and Employee Satisfaction is at an All Time Low August 30, 2017
